MedPath

Initial validation of the Anticipated Adherence Index (AAI) via Community Pharmacies

Not Applicable
Conditions
Any health condition that has required a new or repeat prescription medication
Public Health - Other public health
Registration Number
ACTRN12622000848707
Lead Sponsor
The University of Auckland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
140
Inclusion Criteria

Participants must be picking up a medication prescription for themselves that requires consistent adherence at a community pharmacy, be 18 years of age or over, and be fluent in English.

Exclusion Criteria

Participants will be excluded if prescribed medications are specified to take 'as needed', such as paracetamol or ibuprofen. This is given that such medications do not require consistent adherence.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be responses to the Anticipated Adherence Index (AAI) which will allow for initial Principle Component Analysis (PCA), constrained Principle Component Analysis (PCA), Kaiser-Meyer Olkin Value and Barrett's Test of Sphericity to be utilised to identify and refine the factors within the AAI. [Initial survey measurement<br>];Internal Consistency of the AAI determined by utilising Cronbach's Alpha[Initial survey measurement ];Predictive Validity[Assessing correlation between initial survey measurement of the Anticipated Adherence Index (AAI), and two-week follow up measure of the Brief Adherence Rating Scale (BARS). ]
Secondary Outcome Measures
NameTimeMethod
Test-retest (inter-rater) reliability of the Anticipated Adherence Index (AAI) using Cohen's Kappa[Comparing between initial Anticipated Adherence Index (AAI) measurement, with the two-week followup of the Anticipated Adherence Index (AAI). ]
© Copyright 2025. All Rights Reserved by MedPath